Schmieder RE - Search Results

1

Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium.

Kandzari DE, Mahfoud F, Weber MA, Townsend R, Parati G, Fisher NDL, Lobo MD, Bloch M, Böhm M, Sharp ASP, Schmieder RE, Azizi M, Schlaich MP, Papademetriou V, Kirtane AJ, Daemen J, Pathak A, Ukena C, Lurz P, Grassi G, Myers M, Finn AV, Morice MC, Mehran R, Jüni P, Stone GW, Krucoff MW, Whelton PK, Tsioufis K, Cutlip DE, Spitzer E. Kandzari DE, et al. Among authors: schmieder re. Circulation. 2022 Mar 15;145(11):847-863. doi: 10.1161/CIRCULATIONAHA.121.057687. Epub 2022 Mar 14. Circulation. 2022. PMID: 35286164 Free PMC article. Review.

2

Does obesity influence early target organ damage in hypertensive patients?

Schmieder RE, Messerli FH. Schmieder RE, et al. Circulation. 1993 May;87(5):1482-8. doi: 10.1161/01.cir.87.5.1482. Circulation. 1993. PMID: 8491003

3

Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension.

Schmieder RE, Langenfeld MR, Friedrich A, Schobel HP, Gatzka CD, Weihprecht H. Schmieder RE, et al. Circulation. 1996 Sep 15;94(6):1304-9. doi: 10.1161/01.cir.94.6.1304. Circulation. 1996. PMID: 8822984

4

Renal and systemic hemodynamics in black and white hypertensive patients.

Rockstroh JK, Schmieder RE, Schlaich MP, Messerli FH. Rockstroh JK, et al. Among authors: schmieder re. Am J Hypertens. 1997 Sep;10(9 Pt 1):971-8. doi: 10.1016/s0895-7061(97)00165-9. Am J Hypertens. 1997. PMID: 9324101

5

Comparison of therapeutic studies on regression of left ventricular hypertrophy.

Schmieder RE, Schlaich MP. Schmieder RE, et al. Adv Exp Med Biol. 1997;432:191-8. doi: 10.1007/978-1-4615-5385-4_21. Adv Exp Med Biol. 1997. PMID: 9433526 Review.

6

Does lipoprotein(a) impair endothelial function?

Schlaich MP, John S, Langenfeld MR, Lackner KJ, Schmitz G, Schmieder RE. Schlaich MP, et al. Among authors: schmieder re. J Am Coll Cardiol. 1998 Feb;31(2):359-65. doi: 10.1016/s0735-1097(97)00497-x. J Am Coll Cardiol. 1998. PMID: 9462580 Free article.

7

Inadequate suppression of angiotensin II modulates left ventricular structure in humans.

Schlaich MP, Schobel HP, Langenfeld MR, Hilgers K, Schmieder RE. Schlaich MP, et al. Among authors: schmieder re. Clin Nephrol. 1998 Mar;49(3):153-9. Clin Nephrol. 1998. PMID: 9543596

8

Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).

Schmieder RE, Schlaich MP, Klingbeil AU, Martus P. Schmieder RE, et al. Nephrol Dial Transplant. 1998 Mar;13(3):564-9. doi: 10.1093/ndt/13.3.564. Nephrol Dial Transplant. 1998. PMID: 9550628 Clinical Trial.

9

Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study.

John S, Schlaich M, Langenfeld M, Weihprecht H, Schmitz G, Weidinger G, Schmieder RE. John S, et al. Among authors: schmieder re. Circulation. 1998 Jul 21;98(3):211-6. doi: 10.1161/01.cir.98.3.211. Circulation. 1998. PMID: 9697820 Clinical Trial.

10

Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents.

Schlaich MP, Schmieder RE. Schlaich MP, et al. Among authors: schmieder re. Am J Hypertens. 1998 Nov;11(11 Pt 1):1394-404. doi: 10.1016/s0895-7061(98)00149-6. Am J Hypertens. 1998. PMID: 9832187 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

696 results

Search Page

Filters